Skip to main content
Premium Trial:

Request an Annual Quote

Gates Foundation Awards Multiple Grants for Omics, Dx Projects in August

NEW YORK – The Bill & Melinda Gates Foundation in August awarded more than 100 new grants, several of which are related to omics and diagnostic projects. Following is a selection of these grants including the project title, awardee, funding amount, and duration:

  • Quantigen of Fishers, Indiana, was awarded $1,311,335 over 11 months for a project entitled "Vaginal Swab Validation and POC Diagnostic Assessment for [High-risk] HPV." This grant falls under the topic "Enterics, Diagnostics, and Genomics & Epidemiology."
  • Sherlock Biosciences of Watertown, Massachusetts, was awarded $1,299,440 over 19 months for a project entitled "HPV Molecular Diagnostic Test on Veros Platform." This grant falls under the topic "Enterics, Diagnostics, and Genomics & Epidemiology."
  • The National Institute for Public Health and the Environment of Utrecht, The Netherlands, was awarded $995,255 over 25 months for a project entitled "Integrated serosurveillance technology and expertise transfer to [Low- and Middle-Income Countries]." This grant falls under the topic "Pneumonia & Pandemic Preparedness."
  • Stanford University was awarded $819,863 over 20 months for a project entitled "MBQ1: Microbiome Characterization of Pregnant of Lactating Women." This grant falls under the topic "[Maternal Newborn and Child Health] Discovery and Tools."
  • Rutgers University was awarded $200,000 over 17 months for a project entitled "Multi-pathogen wastewater surveillance in Uganda With CRISPR Cas 12/23." This grant falls under the topic "Discovery and Translational Sciences."
  • Wits Health Consortium of Johannesburg, South Africa, was awarded $97,443 over eight months for a project entitled "Genomic relatedness of neonatal colonizing and invasive [Klebsiella pneumoniae] isolates." This grant falls under the topic "Pneumonia & Pandemic Preparedness."
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.